Rankings
▼
Calendar
MDGL FY 2021 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MDGL
Madrigal Pharmaceuticals, Inc.
$10B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$242M
Net Income
-$242M
EPS (Diluted)
$-14.63
Cash Flow
Operating Cash Flow
-$184M
Free Cash Flow
-$184M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$273M
Total Liabilities
$77M
Stockholders' Equity
$196M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$471,000
+100.0%
Operating Income
-$242M
-$206M
-17.5%
Net Income
-$242M
-$202M
-19.6%
← Q4 2020
All Quarters
Q1 2021 →